Literature DB >> 3519779

Direct monoclonal antibody rosetting. An effective method for weak antigen detection and large scale separation of human mononuclear cells.

M Wilhelm, H Pechumer, G Rank, E Kopp, G Riethmüller, E P Rieber.   

Abstract

A direct monoclonal antibody rosetting technique is described which serves as a simple, reliable, and very sensitive method for the detection of surface antigens on human leukocytes. In this technique the discriminative monoclonal anti-leukocyte antibodies are directly coupled to ox erythrocytes (oxE) by use of CrCl3. The procedure can be applied to the effective separation of mononuclear cell subsets. By choosing a gradient of appropriate density labeled cells are either isolated in high purity or quantitatively eliminated. This technique proved to be particularly suitable for the large scale purification of autologous or allogeneic bone marrow transplants where either leukemic cells or T cells have to be completely eliminated without damaging sensitive stem cells.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3519779     DOI: 10.1016/0022-1759(86)90388-1

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  3 in total

1.  The monoclonal CD4 antibody M-T413 inhibits cellular infection with human immunodeficiency virus after viral attachment to the cell membrane: an approach to postexposure prophylaxis.

Authors:  E P Rieber; C Federle; C Reiter; S Krauss; L Gürtler; J Eberle; F Deinhardt; G Riethmüller
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-15       Impact factor: 11.205

2.  CDw60: a marker for human CD8+ T helper cells.

Authors:  E P Rieber; G Rank
Journal:  J Exp Med       Date:  1994-04-01       Impact factor: 14.307

3.  Induction of Fc epsilon R2/CD23 on human epidermal Langerhans cells by human recombinant interleukin 4 and gamma interferon.

Authors:  T Bieber; A Rieger; C Neuchrist; J C Prinz; E P Rieber; G Boltz-Nitulescu; O Scheiner; D Kraft; J Ring; G Stingl
Journal:  J Exp Med       Date:  1989-07-01       Impact factor: 14.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.